Twynsta
NDC Package 0597-0127-37

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Twynsta is a medication used to treat high blood pressure (hypertension). Marketed by Boehringer Ingelheim Pharmaceuticals, Inc., this product is identified by NDC 0597-0127 and is authorized under FDA application NDA022401.

Identification & Billing

NDC Package Code
0597-0127-37
Package Description
3 BLISTER PACK in 1 CARTON / 10 TABLET, MULTILAYER in 1 BLISTER PACK
Product Code
0597-0127
11-Digit Billing Format
00597012737
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
3 EA

Clinical Specifications

Proprietary Name
Twynsta
Dosage Form
-
Usage Information
This product is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains 2 medications: telmisartan and amlodipine. Telmisartan is an angiotensin receptor blocker (ARB) and amlodipine is a calcium channel blocker. They both work differently to relax the blood vessels so that blood can flow more easily. These medications are used together when one drug is not controlling your blood pressure. Your doctor may direct you to start taking the individual medications first, and then switch you to this combination product if it is the best dose combination for you.

Regulatory & Marketing

Labeler Name
Boehringer Ingelheim Pharmaceuticals, Inc.
FDA Application #
NDA022401
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-02-2009
End Marketing Date
01-31-2020
Listing Expiration
01-31-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0597-0127-37 identifies a specific commercial package of 3 blister pack in 1 carton / 10 tablet, multilayer in 1 blister pack of Twynsta, labeled by Boehringer Ingelheim Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Boehringer Ingelheim Pharmaceuticals, Inc. on November 02, 2009. The current certification is valid through January 31, 2020.

What are the primary indications for this medication?

This product is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains 2 medications: telmisartan and amlodipine. Telmisartan is an angiotensin receptor blocker (ARB) and amlodipine is a calcium channel blocker. They both work differently to relax the blood vessels so that blood can flow more easily. These medications are used together when one drug is not controlling your blood pressure. Your doctor may direct you to start taking the individual medications first, and then switch you to this combination product if it is the best dose combination for you.

How is this Boehringer Ingelheim Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00597012737. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 3 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0597-0127-37
11-Digit CMS (5-4-2)
00597-0127-37

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.